Currently holds positions in Brickell Biotech Inc and BioCryst Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Director | Brickell Biotech Inc | Aug. 31, 2019 - |
Independent Director | BioCryst Pharmaceuticals Inc | May 24, 2017 - |
Senior Vice President, Chief Commercial Officer | Innoviva Inc | April 20, 2016 - Sept. 26, 2018 |
Non-Executive Independent Chairman of the Board | BioCryst Pharmaceuticals Inc | May 1, 2013 - May 24, 2017 |
Senior Vice President - Corporate Partnerships, Commercial | Innoviva Inc | June 12, 2014 - April 20, 2016 |
Independent Director | Ocera Therapeutics Inc | Sept. 19, 2011 - July 15, 2013 |
Independent Director | BioCryst Pharmaceuticals Inc | Oct. 10, 2011 - May 1, 2013 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-04-20 | 2022-04-18 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
PS Planned sale |
5,000
-100.0%
11.0455,200 USD |
5,000 -100.0% | 11.04 | 55,200 USD | |
2021-11-17 | 2021-11-15 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
PS Planned sale |
5,000
-100.0%
12.2761,350 USD |
5,000 -100.0% | 12.27 | 61,350 USD | |
2021-09-17 | 2021-09-15 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
PS Planned sale |
5,000
-100.0%
15.0675,300 USD |
5,000 -100.0% | 15.06 | 75,300 USD | |
2021-09-14 | 2021-09-10 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
S Sale |
74,000
-100.0%
15.091,116,660 USD |
74,000 -100.0% | 15.09 | 1,116,660 USD | |
2021-05-26 | 2021-05-24 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
PS Planned sale |
6,667
-69.0%
13.9092,671 USD |
6,667 -69.0% | 13.90 | 92,671 USD |